Monday , April 12 2021

Experimental Alzheimer's vaccine could halve the number of dementia

A breakthrough in the treatment of dementia?

The researchers found that the experimental vaccine against Alzheimer's disease in the future to halve the number of cases of dementia and can delay the effects of a brain degenerative disease for five years.

Scientists from the University of Texas Southwestern Medical Center have found in a recent study that an experimental vaccine against Alzheimer's disease can reduce the incidence of severe dementia. Doctors revealed the results of their research in the journal in English "The study and treatment of Alzheimer's disease."

New drug could halve the number of cases of dementia in the future. (Image:

The vaccine is shown in animal experiments promising results

The new vaccine has shown promising results in recent animal tests, experts say. Researchers hope that the vaccine also causes similar effects in humans. Way from animal studies to human needs long and tedious, and numerous promising treatment did not take this step. If the vaccine during human studies is safe and effective, it can reduce the total number of diagnoses of dementia by half, explains the author of the study.

Alzheimer's vaccine called often harmful side effects

Dementia is a general term used to describe the symptoms of cognitive disorders include problems with memory, thought, and behavior. Alzheimer's disease & # 39 is the most common cause of dementia, doctors say. The new experimental vaccine marks a monumental step forward in the fight against dementia. Earlier Alzheimer's vaccines cause harmful side effects, including inflammation of the brain, the authors say.

The first successful tests have been completed!

Recently conducted tests on monkeys and rabbits found now that the new vaccine stimulates the body to produce antibodies, which reduce the accumulation of amyloid and tau. These two proteins are generally indicate a degenerative disease of the brain. The vaccine can prolong the lives of people and to prevent the disease spreads in the brain, scientists hope.

The vaccine appears to prevent the accumulation of proteins

If the outbreak of disease could be delayed by five years of drugs, it would be a huge step forward for patients and their seven & # 39; ads. This can reduce the number of cases of dementia by half. The new vaccine appears to be able to stop the accumulation of abnormal protein structures in the brain and the associated neuronal cell death without causing autoimmune inflammation, the researchers wrote in a press release the University of Texas Southwestern Medical Center.

Herpes causes Alzheimer's disease?

According to the Alzheimer's Assocation, a disease with & # 39 is the sixth leading cause of death in the United States. Approximately 5.7 million Americans are currently living with Alzheimer's disease, and researchers believe that the number will increase to 14 million in the year 2050th In the period from 2000 to 2015 the number of deaths increased by 123 percent in the context of Alzheimer's disease.

Professor at the University of Manchester recently said that about half of Alzheimer's disease is associated herpes viruses. A correlation has been hitherto unknown. According to the World Health Organization (WHO) contributes about 3.7 billion people under the age of 50 years (more than 50 percent of the world population), type-1 in the body of herpes simplex virus. (As)

Source link